Search

Your search keyword '"de Boer, N."' showing total 344 results

Search Constraints

Start Over You searched for: Author "de Boer, N." Remove constraint Author: "de Boer, N."
344 results on '"de Boer, N."'

Search Results

2. Scenario-Based Safety Assessment Framework for Automated Vehicles

4. Fecal amine metabolite analysis before onset of severe necrotizing enterocolitis in preterm infants: a prospective case–control study

5. Faecal volatile organic compounds to detect colorectal neoplasia in Lynch syndrome – a prospective multicentre study

9. P190 Identification of clinical risk factors for postoperative endoscopic recurrence in Crohn’s disease: a prospective, multicenter cohort study

10. P818 Imaging-based preoperative body composition is associated with the risk of postoperative complications and postoperative endoscopic recurrence in patients with Crohn’s disease

11. P819 Postoperative prophylaxis prevents surgical and severe endoscopic recurrence after primary ileocecal resection in CD patients

12. OP15 High-definition white light endoscopy with segmental re-inspection is non-inferior compared to dye-based chromoendoscopy in Inflammatory Bowel Disease: the randomized controlled HELIOS trial

15. P909 Proactive therapeutic drug monitoring and pharmacogenomics in mercaptopurine therapy for ulcerative colitis

16. P1078 The influence of different 5-aminosalicylic acid preparations on mercaptopurine metabolism

17. P946 Real life management of patients with active perianal fistulizing Crohn’s disease (ALERT-CD study)

18. P277 Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn’s disease

21. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

22. Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease

23. Longitudinal associations between alcohol use, smoking, genetic risk scoring and symptoms of depression in the general population: A prospective 6-year cohort study

26. P631 Long-term safety of vedolizumab versus other biologic agents in ulcerative colitis (UC) and Crohn’s Disease (CD): Results from a large multinational prospective observational study

28. P526 A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial

33. Fecal amine metabolite analysis before onset of severe necrotizing enterocolitis in preterm infants: a prospective case-control study

35. Additional file 2 of Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn’s disease: a cross-sectional study

37. Additional file 3 of Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn’s disease: a cross-sectional study

39. Longitudinal associations between alcohol use, smoking, genetic risk scoring and symptoms of depression in the general population: a prospective 6-year cohort study.

40. DOP63 Real World Effectiveness, Safety and Pharmacokinetics of Switching Intravenous Vedolizumab Maintenance treatment to Subcutaneous Vedolizumab Therapy for Inflammatory Bowel Disease

44. P126 The predictive value of the modified Rutgeerts score at index endoscopy after primary ileocolic resection in patients with Crohn’s disease for the risk of re-resection and severe endoscopic inflammation after long-term follow-up

46. P284 Prophylactic medication for the prevention of endoscopic recurrence after ileocolonic resection in Crohn’s disease: a prospective study based on clinical risk stratification

47. DOP75 Effectiveness and Safety of tofacitinib versus vedolizumab in Patients with Ulcerative Colitis; A Nationwide, ICC Registry study

Catalog

Books, media, physical & digital resources